ID: h-var-37240814a5
Hypothesis

SASP-Secreted MMP-9 from Senescent Microglia Disrupts Nuclear-Cytoplasmic Transport Leading to TDP-43 Mislocalization and ALS Pathology

This hypothesis proposes that MMP-9 secreted by senescent microglia in the SASP drives ALS pathology through disruption of nuclear-cytoplasmic transport rather than direct proteolytic cleavage of TDP-43.
🧬 MMP9 → NUP62/NUP88 → TARDBP mislocalization🩺 als🎯 Composite 36%💱 $0.46▼24.3%proposed
neurodegeneration
EvidencePending (0%)📖 4 cit🗣 1 debates 4 support 2 oppose
✓ All Quality Gates Passed
Mechanistic 0.53 (15%) Evidence 0.34 (15%) Novelty 0.35 (12%) Feasibility 0.00 (12%) Impact 0.00 (12%) Druggability 0.37 (10%) Safety 0.20 (8%) Competition 0.31 (6%) Data Avail. 0.69 (5%) Reproducible 0.10 (5%) KG Connect 0.50 (8%) 0.361 composite

🧪 Overview

This hypothesis proposes that MMP-9 secreted by senescent microglia in the SASP drives ALS pathology through disruption of nuclear-cytoplasmic transport rather than direct proteolytic cleavage of TDP-43. MMP-9 degrades components of the nuclear pore complex, particularly nucleoporins such as NUP62 and NUP88, which are essential for maintaining the nuclear-cytoplasmic transport machinery. This proteolytic degradation compromises the nuclear import of TDP-43, leading to its aberrant cytoplasmic accumulation and subsequent aggregation. The disrupted transport also impairs the nuclear export of mRNAs that TDP-43 normally regulates, creating a feed-forward loop of RNA metabolism dysfunction. Cytoplasmic TDP-43, now separated from its nuclear targets and present at abnormally high concentrations, undergoes phase separation into pathological aggregates that sequester RNA-binding proteins and disrupt local protein synthesis. These aggregates serve as seeds for prion-like propagation to neighboring neurons through extracellular vesicles or direct cell-to-cell contact.

...

🧬 Mechanism

🧬 Curated Mechanism Pathway

Curated pathway from expert analysis

flowchart TD
    A["MMP9 Zymogen<br/>Proenzyme Activation"]
    B["Pro-MMP9 Cleavage<br/>NGAL or Other Proteases"]
    C["Basement Membrane Degradation<br/>Type IV Collagen Breakdown"]
    D["Blood-Brain Barrier Disruption<br/>Endothelial Tight Junctions"]
    E["Chemokine Release<br/>Proinflammatory Cascade"]
    F["Microglial Activation<br/>CNS Immune Response"]
    G["Neuronal Process Retraction<br/>Dendritic Spine Loss"]
    H["Synaptic Dysfunction<br/>Memory Circuit Impairment"]
    A --> B
    B --> C
    C --> D
    D --> E
    E --> F
    F --> G
    G --> H
    style A fill:#7b1fa2,stroke:#ce93d8,color:#ce93d8
    style H fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a

⚖️ Evidence

⚖️ Evidence Matrix4 supports0 contradicts
Supports
Reactive microglia expressing MMP-9 remodel perineuronal nets around motor neurons in a TDP-43 ALS mouse model.
Neurobiol Dis2024PMID:39067491high
Supports
Reducing MMP-9 protects motor neurons from TDP-43-triggered degeneration in the rNLS8 ALS model.
Neurobiol Dis2019PMID:30458231high
Supports
ALS tissue contains disease-enriched C-terminal TDP-43 fragments measurable by targeted mass spectrometry.
Brain Pathol2022PMID:33300249medium
Supports
C-terminal TDP-43 fragments aggregate readily and injure neurons, supporting their pathogenic relevance once generated.
PLoS One2011PMID:21209826medium
📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — MMP9

🧬 PDB 1GKC Click to expand

Experimental structure from RCSB PDB | Powered by Mol*

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for MMP9 → NUP62 →

No DepMap CRISPR Chronos data found for MMP9 → NUP62.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▲ 0.4%
Volatility
High
0.1615
Events (7d)
2
Price History
▼24.3%

💾 Resource Usage

LLM Tokens
1,719,547
$5.7947
API Calls
297
CPU Time
0.0s
Total Cost
$5.7947
Metadatasource: v1_phase_c_backfill · origin_type: gap_debate
sourcev1_phase_c_backfill
origin_typegap_debate
_schema_version1
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting 0 contradicting 0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.